FindTrial
Sign In

Safety Assessment of Garbhapala Rasa in pregnant women and their respective children

Safety Assessment of Garbhapala Rasa - A Case – Control study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/012005
Enrollment
300
Registered
2018-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: who consumed the drug Garbhapala Rasa during their pregnancy and in their offsprings: who consumed absolutely modern medication during their pregnancy and in their offsprings

Sponsors

Institute for Post Graduate Teaching and Research in Ayurved Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: not applicable

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
The study is expected to provide safety aspects of the formulation that is very much needed in current scenario also expected to provide suitable answers to the concerns being raised on Garbhapala Rasa.Timepoint: 1 year—

Secondary

MeasureTime frame
To publish the observations in indexed journalsTimepoint: 1 year six months—

Countries

India

Contacts

Public ContactDr Shilpa Donga

Institute for Post Graduate Teaching and Research in Ayurved, Jamnagar

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026